Sorry, don’t know. My educated guess – numbers are based on total MCAP of public listed Indian companies i.e. not just limited to NIFTY and/or Sensex stocks. Reason?
- Exhaustive 40+ sector categories; many more than NIFTY coverage.
- Pharma sector 7.88% weightage for 2015 translates to ~7L cr India Pharma MCAP (i.e. 7.88% of ~90L cr India total MCAP). Sum of Sun, Lupin, Cipla, DRL, Cadila, Auro, Glenmark, Divis, GSK, Torrent, Alembic, Ajanta, Shilpa, etc. MCAP comes to ~7L cr.
Data would have few grey entries, understandably e.g. Piramal – Should it be counted in Pharma, Finance or Real Estate?
@vml, this chart is really interesting and useful. Appreciate if you can share how these numbers are calculated – i) coverage width, ii) snapshot of a particular date of year or average, etc? Thanks in advance.
| Subscribe To Our Free Newsletter |
